SCHEMBL21707901

SCHEMBL21707901

Cc1cc(C(F)(C(F)(F)F)C(F)(F)F)cc(Br)c1NC(=O)c1cccc(N(CC2CC2)C(=O)c2ccccc2)c1F

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.39
GPBAR1 Q8TDU6 1/20 0.34
TRPV4 Q9HBA0 3/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
TSHR P16473 1/20 0.32
HSD11B1 P28845 1/20 0.32
MTTP P55157 1/20 0.31
MAPT P10636 1/20 0.31
DHODH Q02127 1/20 0.31
P2RX1 P51575 1/20 0.31
KCNK3 O14649 1/20 0.31
KCNK9 Q9NPC2 1/20 0.31
CRHR1 P34998 1/20 0.30
POLB P06746 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21707903 0.95 HDAC8 (0.39) HDAC8GPBAR1TRPV4HDAC1HDAC6
SCHEMBL21707905 0.92 HDAC8 (0.38) HDAC8GPBAR1TRPV4HDAC1HDAC6
SCHEMBL21707904 0.91 HDAC8 (0.41) HDAC8GPBAR1TRPV4HDAC1HDAC6
SCHEMBL21693652 0.91 HDAC8 (0.36) HDAC8GPBAR1TRPV4HDAC1HDAC6
SCHEMBL29379388 0.89 HDAC8 (0.35) HDAC8GPBAR1HDAC1HDAC6DHODH
SCHEMBL21705045 0.89 HDAC8 (0.35) HDAC8GPBAR1HDAC1HDAC6DHODH
SCHEMBL23264273 0.88 KCNK3 (0.37) HDAC8GPBAR1TRPV4TSHRDHODH
SCHEMBL28362281 0.88 SLC6A2 (0.36) HDAC8GPBAR1HDAC1HDAC6HSD11B1
SCHEMBL28795450 0.88 HDAC8 (0.36) HDAC8GPBAR1
SCHEMBL23264279 0.88 PDE4B (0.34) HDAC8GPBAR1HDAC1HDAC6DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020030095-A1 PHARMACEUTICAL COMPOSITION CONTAINING META-DIAMIDE COMPOUND AND USE THEREOF 上海泰禾国际贸易有限公司 2020-02-13 WO disclosed